Usona Institute Inc

5-meo-dmt phase 2 studyusona institute is conducting a two-part (phase 2a/2b) clinical trial (meo201) to evaluate the efficacy and safety of 5-meo-dmt for the treatment of post-traumatic stress disorder (ptsd) in adults. The goals in part a (phase 2a) are to obtain safety data and effect size estimates in a ptsd patient population and gain knowledge and experience to optimize part b (phase 2b) design. The goal in part b (phase 2b) is to evaluate the safety and efficacy of the 5-meo-dmt regimen selected from part a. 2024 accomplishmentsrefined phase 2 protocols using phase 1 data, optimizing safety and dosing to improve patient outcomes. Initiated site selection and developing facilitator training program to ensure high standards and trial quality. Planning for a 2025 trial launch to evaluate 5-meo-dmt's efficacy with multiple sites in the u.s. And canada.

Events & programsusona's education programs are intentionally designed to provide immersive and interactive learning experiences. These programs focus on preparing clinical, scientific, and academic leaders with the critical knowledge needed to advance psychedelic therapy in clinical research and preparation for future delivery of care, upon approval. Through a carefully tailored curriculum, diverse faculty, experientials, and guest speakers, participants gain the expertise and foundational knowledge required to pave the way for best practices in future care delivery models. 2024 accomplishmentshosted over 300 attendees at ten events at the usona campus in 2024, broadening usona's impact in psychedelic therapy education. Expanded the program offerings and curriculum with immersive programs designed to prepare scientific, clinical, and academic leaders. Awarded full and partial scholarships for participation in usona's immersive education programs, expanding access and diversity of participants. Launched enhanced facilitator training to support the phase 3 psilocybin clinical trial. Strengthened partnerships with research and academic institutions to prepare practitioners and faculty for future care delivery.